Search results for: Precision Medicine
Filter search results
Workshop on HTA and Regulatory Review
13 May 2010
…occur between health technology assessment (HTA) and regulatory approval of medicines. In autumn 2009, OHE and the Institute for Regulatory Science at CMR International collaborated on a two-day workshop on…
Reminder: 2010 Lecture on US Health Reform
14 June 2010
…Medicine. For a summary of Dr Garber’s remarks see these blog posts: Part 1 and Part 2. The full text of his remarks is available in print and by download…
Matthew Napier
11 January 2023
Matthew Napier is a health economist specialising in economic evaluation, health policy, and medicine shortages. He graduated from the University of Birmingham with a distinction in MSc health economics…
Access to Orphan Drugs in the EU
21 October 2010
…lower risk-benefit ratios for OMPs than for other new medicines. When a formal health technology assessment (HTA) process is required, however, evidence requirements are the same as for non-OMP drugs (except…
The UK’s Publicly Funded Vaccines Market
23 November 2010
…and specialised JCVI as the evaluator, rather than NICE, both because of the difference between vaccines and curative prescription medicines and because of the deep expertise of the JCVI membership….
Around the World in HTAs: Japan – An algorithmic approach to containing costs
14 April 2026
…spent on medicines, 70% of budget reductions are due to drug price cuts. The Health Technology Assessment (HTA) system Japan has a centralised pricing system which sets a single national…
Trade Mark Legislation and the Pharmaceutical Industry
1 May 1999
…over the counter (OTC) medicines as well as prescription only medicines. The structure of this report is as follows. Chapter 2 identifies those features of the pharmaceutical industry which set…
Pricing in Emerging Markets: Income, Competition and Procurement
16 August 2011
Most patients in middle and low income countries (MLICs) lack insurance coverage and so pay out of pocket for prescription medicines; pricing commensurate with income thus becomes critical to access…
OHE in the Spotlight: Summer 2011
22 September 2011
…and Processes Value-based pricing (VBP), due to be implemented in the UK for newly marketed medicines as from 2014, remains a key focus of OHE activities. In June, Jon Sussex’s…